Get started
Author

Martyn Ronald Schaafsma

Observed names: M R Schaafsma, M. R Schaafsma, M. R. Schaafsma, M.R. Schaafsma, Martyn R. Schaafsma, Schaafsma, Martyn Ronald
Observed institutions: Medisch Spectrum Twente, Hovon
OpenAlex ID: A5111590780
Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years
2014 · J J Cornelissen, J Versluis, et al. · Leukemia · 137
PDF
Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial
2013 · C. Scheid, P. Sonneveld, et al. · Haematologica · 127
PDF
Apoptosis and Secondary Necrosis of Lymphocytes in Culture
2009 · I. Vermes, C. Haanen, et al. · Acta Haematologica · 61
Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study
2015 · K. M. Holtzer-Goor, M. R. Schaafsma, et al. · Quality of Life Research · 55
PDF
Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy
2004 · M Hoogendoorn, J Olde Wolbers, et al. · Leukemia · 30
Clinical and toxicological aspects of the antineoplastic drug cladribine: A review
1994 · H. -J. Guchelaar, D. J. Richel, et al. · Annals of Hematology · 26
Bortezomib Induction and Maintenance Treatment Improves Survival In Patients With Newly Diagnosed Multiple Myeloma:Extended Follow-Up Of The HOVON-65/GMMG-HD4 Trial
2013 · Pieter Sonneveld, Christof Scheid, et al. · Blood · 24
Final Analysis of HOVON-50 Randomized Phase III Study on the Effect of Thalidomide Combined with Adriamycine, Dexamethasone (AD) and High Dose Melphalan (HDM) in Patients with Multiple Myeloma (MM)
2008 · Henk Lokhorst, Bronno van der Holt, et al. · Blood · 16
Bortezomib Maintenance Therapy after Induction with R-CHOP, ARA-C and Autologous Stem Cell Transplantation in Newly Diagnosed MCL Patients, Results of a Multicenter Phase II HOVON Study
2015 · Jeanette K Doorduijn, Monique C. Minnema, et al. · Blood · 15
First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy
2012 · Francesco d'Amore, Sirpa Leppä, et al. · Blood · 12
Successful Harvesting of Peripheral Hematopoietic Stem Cells after Induction Treatment with Bortezomib, Adriamycin, Dexamethasone (PAD) in Patients with Newly Diagnosed Multiple Myeloma (MM)
2008 · Hartmut Goldschmidt, Henk M. Lokhorst, et al. · Blood · 8
Treatment of Secondary Central Nervous System Lymphoma with Intrathecal Rituximab, High Dose Methotrexate and R-DHAP, Followed by Autologous Stem Cell Transplantation. A Phase II HOVON Study
2012 · Jeanette K Doorduyn, Gustaaf W van Imhoff, et al. · Blood · 6
Effect of Thalidomide with Melphalan and Prednisone on Health-Related Quality of Life (HRQoL) in Elderly Patients with Newly Diagnosed Multiple Myeloma: A Prospective Analysis In a Randomized Trial
2010 · S. Verelst, F. Termorshuizen, et al. · Blood · 5
Ex vivo evidence of lymphocyte apoptosis in hairy cell leukemia, induced by 2-chlorodeoxyadenosine treatment
1998 · C. A. M. Idink-Mecking, D. J. Richel, et al. · Annals of Hematology · 5
Autologous Blood Stem Cell Transplantation Results In Better Relapse-Free Survival Than Consolidation Chemotherapy: Results of a HOVON/SAKK Phase III Trial In 519 AML Patients In First Complete Remission
2010 · Edo Vellenga, Wim van Putten, et al. · Blood · 1
Adoptive Immunotherapy with Donor Lymphocyte Infusions after T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia.
2005 · Renee M.Y. Barge, Eva Steel, et al. · Blood · 1
The Comparative Value of Hematopoietic Stem Cell Transplantation and Chemotherapy in Cytogenetically Normal AML Subclassified By NPM1 Mutation Status and FLT3-ITD Allelic Ratio
2014 · Jurjen Versluis, Raynier Devillier, et al. · Blood
Identification Of Chromosomal Abnormalities By Microarray-Based Genomic Profiling As Compared To Karyotyping In Patients With Low and Intermediate-1 Risk Myelodysplastic Syndromes Within a Prospective Clinical Trial: A Study On Behalf Of The HOVON89 Study Group
2013 · Marian J.P.L. Stevens-Kroef, Annet Simons, et al. · Blood
First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy
2012 · d’Amore, Francesco, Leppa, Sirpa, et al. · GRO
Announcement
2009 · Andreas Lohri, Benoît van Hille, et al. · Acta Haematologica
PDF
ATP Dependent Interferon Responsive (ADIR) Gene Encodes an Activation Induced Minor Histocompatibility Antigen Recognized on Multiple Myeloma by CD8+ T Cells.
2006 · Cornelis A. Van Bergen, Michel G. Kester, et al. · Blood
Primary Allogeneic T-Cell Responses Against In Vitro Modified Mantle Cell Lymphoma (MCL) Cells: Implications for Adoptive Immunotherapy after HLA-Matched Stem Cell Transplantation (SCT).
2004 · M. Hoogendoorn, J. Olde Wolbers, et al. · Blood
Works count: 23
Citation count: 529
H-index: 10
I10-index: 10
Year
Topic
Type